These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 12374693

  • 1. Antibody to vascular endothelial growth factor slows growth of an androgen-independent xenograft model of prostate cancer.
    Fox WD, Higgins B, Maiese KM, Drobnjak M, Cordon-Cardo C, Scher HI, Agus DB.
    Clin Cancer Res; 2002 Oct; 8(10):3226-31. PubMed ID: 12374693
    [Abstract] [Full Text] [Related]

  • 2. Paclitaxel enhances the effects of the anti-epidermal growth factor receptor monoclonal antibody ImClone C225 in mice with metastatic human bladder transitional cell carcinoma.
    Inoue K, Slaton JW, Perrotte P, Davis DW, Bruns CJ, Hicklin DJ, McConkey DJ, Sweeney P, Radinsky R, Dinney CP.
    Clin Cancer Res; 2000 Dec; 6(12):4874-84. PubMed ID: 11156247
    [Abstract] [Full Text] [Related]

  • 3. Vascular endothelial growth factor immunoneutralization plus Paclitaxel markedly reduces tumor burden and ascites in athymic mouse model of ovarian cancer.
    Hu L, Hofmann J, Zaloudek C, Ferrara N, Hamilton T, Jaffe RB.
    Am J Pathol; 2002 Nov; 161(5):1917-24. PubMed ID: 12414537
    [Abstract] [Full Text] [Related]

  • 4. Antiangiogenic and antitumor activity of anti-epidermal growth factor receptor C225 monoclonal antibody in combination with vascular endothelial growth factor antisense oligonucleotide in human GEO colon cancer cells.
    Ciardiello F, Bianco R, Damiano V, Fontanini G, Caputo R, Pomatico G, De Placido S, Bianco AR, Mendelsohn J, Tortora G.
    Clin Cancer Res; 2000 Sep; 6(9):3739-47. PubMed ID: 10999768
    [Abstract] [Full Text] [Related]

  • 5. Anti-VEGF antibody in experimental hepatoblastoma: suppression of tumor growth and altered angiogenesis.
    McCrudden KW, Hopkins B, Frischer J, Novikov A, Huang J, Kadenhe A, New T, Yokoi A, Yamashiro DJ, Kandel JJ, Middlesworth W.
    J Pediatr Surg; 2003 Mar; 38(3):308-14; discussion 308-14. PubMed ID: 12632340
    [Abstract] [Full Text] [Related]

  • 6. Anti-vascular endothelial growth factor receptor 2 antibody reduces tumorigenicity and metastasis in orthotopic prostate cancer xenografts via induction of endothelial cell apoptosis and reduction of endothelial cell matrix metalloproteinase type 9 production.
    Sweeney P, Karashima T, Kim SJ, Kedar D, Mian B, Huang S, Baker C, Fan Z, Hicklin DJ, Pettaway CA, Dinney CP.
    Clin Cancer Res; 2002 Aug; 8(8):2714-24. PubMed ID: 12171905
    [Abstract] [Full Text] [Related]

  • 7. Response of prostate cancer to anti-Her-2/neu antibody in androgen-dependent and -independent human xenograft models.
    Agus DB, Scher HI, Higgins B, Fox WD, Heller G, Fazzari M, Cordon-Cardo C, Golde DW.
    Cancer Res; 1999 Oct 01; 59(19):4761-4. PubMed ID: 10519379
    [Abstract] [Full Text] [Related]

  • 8. Treatment of human metastatic transitional cell carcinoma of the bladder in a murine model with the anti-vascular endothelial growth factor receptor monoclonal antibody DC101 and paclitaxel.
    Inoue K, Slaton JW, Davis DW, Hicklin DJ, McConkey DJ, Karashima T, Radinsky R, Dinney CP.
    Clin Cancer Res; 2000 Jul 01; 6(7):2635-43. PubMed ID: 10914704
    [Abstract] [Full Text] [Related]

  • 9. Potentiation of the antiangiogenic ability of linomide by androgen ablation involves down-regulation of vascular endothelial growth factor in human androgen-responsive prostatic cancers.
    Joseph IB, Isaacs JT.
    Cancer Res; 1997 Mar 15; 57(6):1054-7. PubMed ID: 9067270
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of growth factor production and angiogenesis in human cancer cells by ZD1839 (Iressa), a selective epidermal growth factor receptor tyrosine kinase inhibitor.
    Ciardiello F, Caputo R, Bianco R, Damiano V, Fontanini G, Cuccato S, De Placido S, Bianco AR, Tortora G.
    Clin Cancer Res; 2001 May 15; 7(5):1459-65. PubMed ID: 11350918
    [Abstract] [Full Text] [Related]

  • 11. Dual inhibition of the epidermal growth factor and vascular endothelial growth factor phosphorylation for antivascular therapy of human prostate cancer in the prostate of nude mice.
    Yazici S, Kim SJ, Busby JE, He J, Thaker P, Yokoi K, Fan D, Fidler IJ.
    Prostate; 2005 Nov 01; 65(3):203-15. PubMed ID: 15948138
    [Abstract] [Full Text] [Related]

  • 12. VEGF-mediated angiogenesis of human pheochromocytomas is associated to malignancy and inhibited by anti-VEGF antibodies in experimental tumors.
    Zielke A, Middeke M, Hoffmann S, Colombo-Benkmann M, Barth P, Hassan I, Wunderlich A, Hofbauer LC, Duh QY.
    Surgery; 2002 Dec 01; 132(6):1056-63; discussion 1063. PubMed ID: 12490855
    [Abstract] [Full Text] [Related]

  • 13. Vascular endothelial growth factor monoclonal antibody inhibits growth of anaplastic thyroid cancer xenografts in nude mice.
    Bauer AJ, Terrell R, Doniparthi NK, Patel A, Tuttle RM, Saji M, Ringel MD, Francis GL.
    Thyroid; 2002 Nov 01; 12(11):953-61. PubMed ID: 12490072
    [Abstract] [Full Text] [Related]

  • 14. Neutralizing anti-vascular endothelial growth factor antibody inhibits further growth of established prostate cancer and metastases in a pre-clinical model.
    Melnyk O, Zimmerman M, Kim KJ, Shuman M.
    J Urol; 1999 Mar 01; 161(3):960-3. PubMed ID: 10022734
    [Abstract] [Full Text] [Related]

  • 15. Blockade of epidermal growth factor receptor signaling in tumor cells and tumor-associated endothelial cells for therapy of androgen-independent human prostate cancer growing in the bone of nude mice.
    Kim SJ, Uehara H, Karashima T, Shepherd DL, Killion JJ, Fidler IJ.
    Clin Cancer Res; 2003 Mar 01; 9(3):1200-10. PubMed ID: 12631626
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of angiogenesis by the antiepidermal growth factor receptor antibody ImClone C225 in androgen-independent prostate cancer growing orthotopically in nude mice.
    Karashima T, Sweeney P, Slaton JW, Kim SJ, Kedar D, Izawa JI, Fan Z, Pettaway C, Hicklin DJ, Shuin T, Dinney CP.
    Clin Cancer Res; 2002 May 01; 8(5):1253-64. PubMed ID: 12006546
    [Abstract] [Full Text] [Related]

  • 17. Combination antiangiogenic therapy: increased efficacy in a murine model of Wilms tumor.
    Soffer SZ, Moore JT, Kim E, Huang J, Yokoi A, Manley C, O'Toole K, Stolar C, Middlesworth W, Yamashiro DJ, Kandel JJ.
    J Pediatr Surg; 2001 Aug 01; 36(8):1177-81. PubMed ID: 11479851
    [Abstract] [Full Text] [Related]

  • 18. A murine vascular endothelial growth factor antibody inhibits in vivo growth of human Caki-I renal adenocarcinoma.
    Dagnaes-Hansen F, Rasmussen LM, Tilton R, Denner L, Flyvbjerg A.
    Anticancer Res; 2003 Aug 01; 23(2B):1625-30. PubMed ID: 12820432
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Inhibition of tumor growth and metastasis by an immunoneutralizing monoclonal antibody to human vascular endothelial growth factor/vascular permeability factor121.
    Asano M, Yukita A, Matsumoto T, Kondo S, Suzuki H.
    Cancer Res; 1995 Nov 15; 55(22):5296-301. PubMed ID: 7585591
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.